ETM Experimental and Therapeutic Medicine 1792-0981 1792-1015 D.A. Spandidos ETM-0-0-09995 10.3892/etm.2021.9995 Articles Alliin inhibits adipocyte differentiation by downregulating Akt expression: Implications for metabolic disease LiNi 1 2 * ChenKai 3 * DongHongwei 2 YangJing 4 YoshizawaMichiko 2 5 KagamiHideaki 2 4 LiXianqi 2 4 5 Department of Stomatology, Zhongshan Hospital, Fudan University, Shanghai 200031, P.R. China Department of Hard Tissue Research, Graduate School of Oral Medicine, Matsumoto Dental University, Shiojiri, Nagano 399-0781, Japan Department of Stomatology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, P.R. China Department of Hard Tissue Research, Institute for Oral Science, Matsumoto Dental University, Shiojiri, Nagano 399-0781, Japan Department of Oral and Maxillofacial Surgery, School of Dentistry, Matsumoto Dental University, Shiojiri, Nagano 399-0781, Japan Correspondence to: Dr Xianqi Li, Department of Hard Tissue Research, Graduate School of Oral Medicine, Matsumoto Dental University, 1780 Hirookagobara, Shiojiri, Nagano 399-0781, Japan xianqi.li@mdu.ac.jp

*Contributed equally

 06 2021 26 03 2021 21 6 563 23 03 2020 23 07 2020 Copyright: © Li et al. 2021 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Obesity is currently an important health problem and is associated with an increased likelihood of various diseases. The efficacies of various natural treatments have been assessed for their utility in treating obesity. Alliin (S-allyl-L-cysteine sulfoxides) is considered the major component of garlic and has a wide range of natural antioxidant properties. However, the direct effects of alliin on obesity have not been well clarified. The present study investigated the effects and possible mechanisms of alliin on adipocyte differentiation. The 3T3-L1 cells were treated with alliin (0-40 µg/ml) during adipogenic differentiation. The effect of alliin on lipid accumulation was evaluated by Oil red O staining. Reverse transcription-quantitative PCR was performed to investigate the expression levels of adipogenic differentiation-related genes. The accumulation of lipid droplets was markedly inhibited following alliin treatment. The expression levels of multiple adipogenic transcription markers, such as CCAAT/enhancer-binding protein (C/EBP) β, C/EBP α and peroxisome proliferation-activity receptor γ, were markedly decreased following treatment with alliin during adipogenic differentiation. Expression levels of several adipocyte-related genes were subsequently suppressed. Additionally, alliin suppressed PKB/Akt and PI3K expression. These results suggested that alliin exhibits anti-adipogenic activity by downregulating major adipogenic differentiation-related genes and Akt/PI3K expression. Alliin may have a potential therapeutic effect on metabolic disease.

 alliin adipogenesis metabolic disease peroxisome proliferation-activity receptor γ CCAAT/enhancer-binding protein β Akt Funding: The present study was supported in part by Grants-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science (JSPS; KAKENHI grant no. JP19K10192). Introduction

Obesity is a significant risk factor for many metabolic diseases such as obstructive sleep apnea, cardiovascular diseases, diabetes, cancers, and osteoarthritis (1,2). Obesity can be considered a consequence of energy imbalance, which causes an increase in differentiated adipocytes and excessive fat accumulation (3,4). Adipogenesis, the process of maturation of preadipocytes, is an integrated process involving the activation of several signaling pathways (5). The transcription factors such as the peroxisome proliferation-activity receptor (PPAR) γ and CCAAT/enhancer-binding protein (C/EBP) family are crucial for adipogenesis (6-8). These major adipogenic-related factors control the expression of the lipid metabolizing enzymes to form mature adipocytes. C/EBP families are expressed at certain times in the process of adipogenesis. C/EBP β and C/EBP δ promoters are activated in the early stage of differentiation and act in the direct regulation of adipogenesis (9). Activated C/EBP β then regulate its neighboring promoter element, which subsequently encodes the PPAR γ and C/EBP α genes during the later stage of differentiation (10,11). The major transcription factors upregulate adipocyte differentiation-related genes such as adiponectin, leptin, and fatty acid binding protein (Fabp4) during adipocyte differentiation (12,13). Therefore, the control of adipogenesis involves suppressing this transcriptional regulation. Many signaling pathways influence adipocyte differentiation. The Akt pathway and the extracellular signal-regulated kinase (ERK) 1/2 pathway are shown to be responsible for adipogenesis (14,15). The Akt is in a key position to promote insulin-like growth factor-1 expression and adipocyte differentiation, while Akt pathway inhibition is shown to reduce adipogenesis (16).

Many studies have focused on developing anti-obesity drugs (17). Although several drugs are currently available to treat obesity, their long-term use may cause severe side effects (18). Thus, multiple research studies are focused on new natural products with potential for anti-obesity activity (19). The anti-obesity activity of various plant extracts is reported to be mediated by the regulation of adipogenesis (20). Garlic (Allium sativum), one of the oldest medicinal plants, is originally from Asia. Allium vegetables comprise one of the natural sources of organosulfur compounds and show advantages in therapeutic application, mostly owing to their cardiovascular protective effects, lowering of cholesterol, and anti-cancer properties (21). In addition, Allium has possibly beneficial effects in the treatment of obesity by adipogenesis inhibition (22), energy expenditure increase (23) and influence on expression of inflammatory mediators from serum (24). The synthesis of alliin (S-allyl-L-cysteine sulfoxide, SACSO), considered to be the major component of garlic, was first reported by Stoll and Seebeck in 1951(25). Alliin, which has strong antioxidant properties, has been used as a treatment remedy for some diseases (26,27). Previous research found that alliin can help in decreasing the serum levels of glucose and insulin (28). Alliin also can regulate the anti-inflammatory effects of preadipocytes by reducing cytokine levels, such as IL-6 and TNF (29). Alliin was shown to possess many biological effects. However, the direct effect of alliin in adipogenesis has not yet been explored. The aim of this study was to evaluate the effects of alliin on the adipogenic differentiation of 3T3-L1 cells and its potential association with the regulation of adipogenic transcription factors PPAR γ, C/EBP, adiponectin and Fabp4, as well as possible mechanism.

 Materials and methods <sec> <title>Materials

Alliin, obtained from Abcam (ab141896), was dissolved in dimethylsulfoxide (DMSO), and stored at -20˚C.

 Cell culture

3T3-L1 fibroblasts were obtained from Japanese Collection of Research Bioresources Cell Bank (Osaka, Japan). Cells were cultured in DMEM (Sigma-Aldrich; Merck KGaA) supplemented with 10% fetal bovine serum (FBS; Gibco Life Technologies), 100 U/ml penicillin, 100 µg/ml streptomycin, and 0.25 µg/ml amphotericin B (Biological Industries) in a CO2 ncubator. The cells were then trypsinized after reaching 80-90% confluence. Cells at passages 2-15 were used in this study.

 Adipocyte differentiation

The cells were differentiated following previously reported method with some modifications (30). Briefly, adipocyte differentiation begins after cell cultures reached 100% confluence. For adipogenic induction, the medium used was DMEM containing 10% FBS, 1 µM dexamethasone (Sigma-Aldrich; Merck KGaA), 0.5 mM 3-isobutyl-1-methylxanthine (Wako), and 10 µg/ml insulin (Funakoshi Co. Ltd.) for 2 days. The cells were then transferred to DMEM containing 10% FBS and 10 µg/ml insulin for 6 days. The medium was changed every 2-3 days. Mature adipocytes were obtained on day 7 or 8. To evaluate the effects of alliin on adipogenesis, various concentrations of alliin (10-40 µg/ml) were used during the induction process. Cells that were not treated with alliin were identified as the control.

 Oil red O staining

To confirm the lipid accumulation in cultured cells, Oil red O staining (Sigma-Aldrich; Merck KGaA) was performed. Eight days after induction, mature adipocytes were fixed with 4% paraformaldehyde phosphate buffer solution for 30 min at room temperature and then stained with Oil red O working solution (6:4 of oil red stock solution: Distilled water) for 15 min. PBS was washed three times to remove the excess Oil red O dye. The images were observed under a parallel phase contrast microscope (Olympus IX70 inverted microscope, Olympus Optical CO, Ltd.). For quantitative analysis, the percentage of positively stained areas were calculated using imageJ. Results are expressed as percentage of Oil red O-stained area compared to control. For each sample, the experiments were performed in triplicates.

 Measurement of cell viability

Cell viability was determined using a Cell Counting Kit-8 assay (CCK-8; DOJINDO Lab, Osaka, Japan). 3T3-L1 cells were seeded in 96-well plates (5x103 cells/well) for 2 days. Cells were then cultured with various concentrations of alliin (0-40 µg/ml) for 7 days. Cell Counting Kit-8 (CCK-8; Dojindo Laboratories) was used according the manufacturer's instruction. Cells were incubated with 10 µl of CCK-8 reagent for 2 h at 37˚C. The result was determined using a Synergy™ HTX Multi-Mode Microplate Reader (BioTek Instruments) at 450 nm.

 Reverse transcription-quantitative PCR (RT-qPCR)

Total RNA was extracted from cells using TRIzol® reagent (Ambion®; Gibco Life Technologies) according to manufacturer's instructions. The quantity and quality of isolated RNA were detected using a Nano Drop spectrophotometer (Nano Drop® ND-1000, Thermo Fisher Scientific, Inc.). Complementary DNA (cDNA) was synthesized in a 20-µl reaction using 2 µg RNA, 20 pmol Oligo dT12-18 (Invitrogen; Thermo Fisher Scientific, Inc., 18418-012), 0.5 µl RNase inhibitor (Promega Corporation, N211A), 0.2 µl ReverTra Ace (Toyobo, TRT-101), 2 µl dNTP Mixture (Takara, 4030), 4 µl 5X RT buffer (Toyobo, TRT-101), and 10 mM DEPC water. RT-qPCR was performed in a 25-µl reaction, containing 1 µl cDNA, 10 pmol forward and reverse primers, and 12.5 µl SYBR Premix Ex Taq II (Takara, RR820A). PCR amplification was set as follows: 95˚C for 30 sec, 40 cycles of 95˚C for 5 sec, and 60˚C for 30 sec; then the final dissociation was set at 95˚C for 15 sec, 60˚C for 30 sec, and 95˚C for 15 sec. The data were quantified using the 2-∆∆Cq method and were normalized against the levels of β-actin (31). The primer sequences used for PCR are provided in Table I.

 Statistical analysis

The results are presented as the mean ± standard error of the mean (SEM) of three experiments. SPSS 13.0 and GraphPad Prism 6 software were used for statistical analysis. The statistical significance between each group was computed using one-way analysis of variance followed by Dunnett's test. P<0.05 was considered statistically significant.

 Results <sec> <title>Effect of alliin on intracellular lipid accumulation during adipogenic differentiation

3T3-L1 cells showed fibroblastic-like morphology before adipogenic induction (Fig. 1A-a and -b). Then, the suppression effect of alliin on adipogenic differentiation was examined. During adipogenic differentiation, the 3T3-L1 cells were treated with different concentrations of alliin (10, 20, 40 µg/ml) for 7 days, and the cells treated without alliin were used as control. 3T3-L1 cells showed a morphological change from fibroblastic-shape to round-shape, and then oil droplets were formed and maintained after 7 days of induction (Fig. 1A-c-f). Oil red O staining was performed to evaluate lipid accumulation levels. The Oil red O-stained area decreased significantly in the alliin-treated groups compared with the control group (Fig. 1A-g-j). Meanwhile, quantitative analysis showed that alliin-treated group displayed dramatically lower lipid accumulation in a dose-dependent manner compared to the control group. 40 µg/ml alliin treatment showed the greatest effects on the lipid accumulation which level dropped to 39.5% (Fig. 1B). The effect of alliin on cell viability was examined. 3T3-L1 cells were treated with different concentrations of alliin (10-40 µg/ml) for 7 days. Alliin has no effect on cell viability even at a concentration of 40 µg/ml (Fig. 1C). These data indicated that alliin may contain anti-adipogenic potential.

 Effect of alliin on adipogenic transcription markers C/EBP β, C/EBP α, and PPAR γ

To examine the effect of alliin on adipogenic transcription markers during induction, cells were analyzed by RT-qPCR. The expression levels of C/EBP β, C/EBP α and PPAR γ were assessed on dayz 1, 3 and 7 of induction, respectively. The mRNA level of C/EBP β, induced by the differentiation medium, reached its peak on day 1, and then decreased gradually over time. Cells treated with 40 µg/ml alliin on day 3 showed a significant decrease in lipid accumulation compared to cells in the control group, but there was no significant difference on day 7 (Fig. 2A). The expression of C/EBP α and PPAR γ were gradually induce during adipogenic differentiation in control group. Expression level of C/EBP α was significantly reduced by treatment with 40 µg/ml alliin compared to without treatment on day 1 and day 7 (Fig. 2B) Treatment with 40 µg/ml alliin also significantly inhibited the expression of PPAR γ on day 7 (Fig. 2C). These results indicate that 40 µg/ml alliin suppress adipogenesis by downregulating the expression of C/EBP α and PPAR γ.

 Effect of alliin on adipocyte-related genes adiponectin, Fabp4, and leptin

Expression of adipocyte-related genes was also analyzed using RT-qPCR. During adipogenic differentiation, expression of adiponectin mRNA increased over time. The level of adiponectin mRNA was significantly lower with treatment of 40 µg/ml alliin than without treatment at all time points examined (Fig. 3A). The level of Fabp4 mRNA was significantly decreased in cells cultured with 40 µg/ml alliin than in those without treatment on day 1 and day 7 (Fig. 3B). Whereas, the level of leptin mRNA was significantly lower in the 40 µg/ml alliin treatment group than in the control group on day 1 (Fig. 3C). These results indicate that 40 µg/ml alliin inhibits adipogenesis and leads to reduce expression of adiponectin and Fabp4.

 Effect of Alliin on the Akt and ERK 1/2 pathways related genes during adipogenic differentiation

Akt and ERK 1/2 are upstream regulators in the adipocyte differentiation pathway, including C/EBP α and PPAR γ pathways. To investigate the possible mechanism of alliin on adipogenic differentiation, the Akt and ERK 1/2 pathways related genes were examined. The 3T3-L1 cells were cultured with various concentrations of alliin during the differentiation of adipocyte. Results showed that expression of PI3K and Akt was significantly increased at the early stage of differentiation. Expression of PI3K was significantly inhibited in the 20 or 40 µg/ml alliin treatment group compared to that in the control group at all time points examined (Fig. 4A). The level of AKT mRNA was significantly lower with treatment of 40 µg/ml alliin than without treatment on days 3 and 7 (Fig. 4B). However, increased expression of MAPK and ERK was observed in the treatment groups compared to that in the control groups on day 7 (Fig. 4C). The level of ERK mRNA increased significantly with 40 µg/ml alliin treatment compared to that without treatment after 7 days (Fig. 4D). These results suggest that 40 µg/ml alliin inhibits adipocyte differentiation by reducing the expression of PI3K and Akt.

 Discussion

In the current study, we indicated that alliin treatment may contribute to decreased adipogenesis of 3T3-L1 adipocyte. This study revealed, for the first time, the direct effect of alliin on adipogenesis. Moreover, we found an effect of alliin on adipogenesis may be achieved by downregulating the Akt and PI3K expression. Several recent reports indicate the benefit of plant extracts as drugs (19,32). Compared to conventional drugs, herbal medicines show less potentially dangerous side effects. Many plant compounds, such as ginsenoside, caffeic acid, berberine, anthocyanin, and capsaicin, have been shown to inhibit adipogenesis (33-35).

Obesity is commonly caused by an excessive increase of adipocytes. Adipogenesis is a complex regulated cellular differentiation process involving many signaling pathways and related molecules (36,37). The inhibition of adipogenesis process can provide a target for the control and treatment of obesity. During 3T3-L1 adipocyte differentiation, C/EBP β is rapidly induced and is responsible for activating the adipogenic regulators C/EBP α and PPAR γ (38). PPAR γ plays a crucial role in adipogenesis of embryonic stem cells and fibroblasts. PPAR γ levels are significantly induced when preadipocytes are converted into adipocytes (39,40). The research suggested that white adipose tissue under obesity condition a significant increment in oxidative stress, pro-inflammatory status and depletion of n-3 long chain polyunsaturated fatty acid (n-3 LCPUFA) (41). Whereas PPAR γ transcription factor is regulated by n-3 LCPUFA that participate in the metabolism of adipose tissue (42). So, the regulation of adipogenesis occurs by controlling PPAR γ levels (20). Moreover, PPAR γ has been shown to induce and activate the transcriptional factor C/EBP α promoter (43). C/EBP α is a transcriptional factor of the C/EBP family and also plays an important role in regulating adipogenesis (44). Thus, PPAR γ and C/EBP α genes are upregulated and together activate the adipogenesis pathways (45). In this study, a direct effect of alliin on adipocyte differentiation was performed. Alliin significantly decreased the lipid droplet accumulation. Expression level of C/EBP β was significantly decreased in presence of 40 µg/ml alliin on day 3. Expression of C/EBP α and PPAR γ was lower with 40 µg/ml alliin treatment on day 7, while the level of C/EBP β was not affected. These result may correspond to C/EBP β induced in the early stage of differentiation that subsequently activates the adipogenesis markers, PPAR γ and C/EBP α, at the later stage of differentiation. The results suggest that alliin may inhibit adipogenesis by reducing C/EBP β, C/EBP α, and PPAR γ levels during adipocyte differentiation.

In addition, PPAR γ and C/EBP α can be part of a feedback loop and promote adipogenesis by leading the expression of downstream genes, such as adiponectin, Fabp4, and leptin. These downstream genes play major roles in inducing and maintaining mature adipocytes (5). A recent study indicated that the expression of adipocyte-related genes during induction is PPAR γ dependent (46). In the alliin treatment group, expression of leptin was lower during the early stage of differentiation, while the level was not affected at day 7. This may be due to the existence of different regulatory mechanisms of leptin expression. Recent study noted that leptin can directly induce the adipocyte differentiation in the early stage of adipogenesis, while showing anti-adiposity effects after maturation of adipocytes (47). Expression of adiponection and Fabp4 was significantly inhibited with alliin treatment after adipocyte induction. These results clearly imply that alliin inhibits adipogenic differentiation by reducing the expression of adipocyte-related genes, which may be through the repression of PPAR γ and C/EBP α related pathways.

Insulin signaling pathway plays a critical role in modulating adipogenesis. In the presence of insulin, the insulin receptor is autophosphorylated, and subsequently proteins in the insulin receptor substrate family are also phosphorylated, thereby activating the two main signaling pathways, PI3K/Akt and MAPK/ERK pathways (48). The function of PI3K/Akt signaling is to activate adipogenic transcription marker such as C/EBP α and promote adipocyte maturation during adipogenesis (49). A study also showed that expression of PPAR γ is significantly impeded in Akt-deficient mice (50). Thus, inhibition of PI3K/Akt signaling pathway may provide a therapeutic target for obesity (51). The MAPK/ERK signaling pathway plays a complicated role in the regulation of adipogenesis. Activation of the MAPK/ERK pathway can both inhibit and promote adipocyte differentiation. Tanabe et al (52) reported that the MAPK/ERK pathway works in a suppressive manner on adipocyte differentiation when receiving a long-term or sustained stimulation. In this study, the higher expression levels of ERK with alliin treatment may correspond to the inhibition effects of MAPK pathway on adipogenesis. In contrast, the expression level of P13K and Akt mRNA expression were markedly decreased with alliin treatment. Collectively, our study indicated that alliin resulted in PI3K/Akt inhibition, thereby suppressing the expression of C/EBP β, C/EBP α, and PPAR γ and adipocyte-related genes (Fig. 5). Although the results from this study indicated that the Akt signaling pathway play an important role in alliin inhibit adipocyte differentiation, there are still limitations. First, the phosphorylation levels of Akt signaling related proteins should be test. Second, whether the validity of this theory still needs further experimental investigation.

In conclusion, the results demonstrated that alliin in garlic can inhibit adipogenesis by reducing expression of major transcriptional activators and their downstream genes, which may be mediated by regulation of Akt signaling pathway. Alliin may provide a possible naturally occurring therapeutic method for the prevention and treatment of metabolic disease.

 Acknowledgements

Not applicable.

 Availability of data and materials

All data generated or analyzed during this study are included in this published article.

 Authors' contributions

NL and KC performed all experiments, acquired data, analyzed the data and drafted the manuscript. . KC and HD contributed to the acquisition of data. JY, MY, HK and XL designed the experiment. XL revised the manuscript. All authors read and approved the final manuscript.

 Ethics approval and consent to participate

Not applicable.

 Patient consent for publication

Not applicable.

 Competing interests

The authors declare that they have no competing interests.

 References WilsonPWBozemanSRBurtonTMHoaglinDCBen-JosephRPashosCLPrediction of first events of coronary heart disease and stroke with consideration of adiposityCirculation11812413020081859143210.1161/CIRCULATIONAHA.108.772962 JehanSMyersAKZiziFPandi-PerumalSRJean-LouisGMcFarlaneSIObesity, obstructive sleep apnea and type 2 diabetes mellitus: Epidemiology and pathophysiologic insightsSleep Med Disord25258201830167574 FariaSLFariaOPMenezesCSde GouvêaHRde Almeida CardealMMetabolic profile of clinically severe obese patientsObes Surg221257126220122252759510.1007/s11695-012-0651-y JéquierETappyLRegulation of body weight in humansPhysiol Rev7945148019991022198710.1152/physrev.1999.79.2.451 MosetiDRegassaAKimWKMolecular regulation of adipogenesis and potential anti-adipogenic bioactive moleculesInt J Mol Sci1712420162679760510.3390/ijms17010124 RosenEDHsuCHWangXSakaiSFreemanMWGonzalezFJSpiegelmanBMC/EBPalpha induces adipogenesis through PPARgamma: A unified pathwayGenes Dev16222620021178244110.1101/gad.948702 El-JackAKHammJKPilchPFFarmerSRReconstitution of insulin-sensitive glucose transport in fibroblasts requires expression of both PPARgamma and C/EBPalphaJ Biol Chem2747946795119991007569110.1074/jbc.274.12.7946 LefterovaMILazarMANew developments in adipogenesisTrends Endocrinol Metab2010711420091926984710.1016/j.tem.2008.11.005 TanakaTYoshidaNKishimotoTAkiraSDefective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta geneEMBO J16743274431997940537210.1093/emboj/16.24.7432 ClarkeSLRobinsonCEGimbleJMCAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator-activated receptor gamma2 promoterBiochem Biophys Res Commun240991031997936789010.1006/bbrc.1997.7627 FarmerSRTranscriptional control of adipocyte formationCell Metab426327320061701149910.1016/j.cmet.2006.07.001 WeiSZanLSWangHBChengGDuMJiangZHausmanGJMcfarlandDCDondsonMVAdenovirus-mediated interference of FABP4 regulates mRNA expression of ADIPOQ, LEP and LEPR in bovine adipocytesGenet Mol Res1249450520192331588010.4238/2013.January.4.21 RosenEDWalkeyCJPuigserverPSpiegelmanBMTranscriptional regulation of adipogenesisGenes Dev1412931307200010837022 TsengYHButteAJKokkotouEYechoorVKTaniguchiCMKriauciunasKMCypessAMNiinobeMYoshikawaKPattiMEKahnCRPrediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdinNat Cell Biol760161120051589507810.1038/ncb1259 PrustyDParkBHDavisKEFarmerSRActivation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytesJ Biol Chem277462264623220021227093410.1074/jbc.M207776200 GuoLXChenGYinZYZhangYHZhengXXP-Synephrine exhibits anti-adipogenic activity by activating the Akt/GSK3β signaling pathway in 3T3-L1 adipocytesJ Food Biochem43e1303320193148609210.1111/jfbc.13033 PowellAGApovianCMAronneLJNew drug targets for the treatment of obesityClin Pharmacol Ther90405120112165474210.1038/clpt.2011.82 YanovskiSZYanovskiJALong-term drug treatment for obesity: A systematic and clinical reviewJAMA311748620142423187910.1001/jama.2013.281361 KumarPBhandariUCommon medicinal plants with antiobesity potential: A special emphasis on fenugreekAnc Sci Life35586320152660066910.4103/0257-7941.165629 HatanoTSameshimaYKawabataMYamadaSShinozukaKNakabayashiTMizunoHSt. John's wort promotes adipocyte differentiation and modulates NF-κB activation in 3T3-L1 cellsBiol Pharm Bull371132113820142498900510.1248/bpb.b13-00989 MikailiPMaadiradSMoloudizargariMAghajanshakeriSSarahroodiSTherapeutic uses and pharmacological properties of garlic, shallot, and their biologically active compoundsIran J Basic Med Sci1610311048201324379960 KimHJLeeMJJangJYLeeSHAllium hookeri root extract inhibits adipogenesis by promoting lipolysis in high fat diet-induced obese miceNutrients11226220193154703110.3390/nu11102262 KagawaYOzaki-MasuzawaYHosonoTSekiTGarlic oil suppresses high-fat diet induced obesity in rats through the upregulation of UCP-1 and the enhancement of energy expenditureExp Ther Med191536154020203201033510.3892/etm.2019.8386 XuCMathewsAERodriguesCEudyBJRoweCAO'DonoughueAPercivalSSAged garlic extract supplementation modifies inflammation and immunity of adults with obesity: A randomized, double-blind, placebo-controlled clinical trialClin Nutr ESPEN2414815520182957635410.1016/j.clnesp.2017.11.010 StollASeebackEChemical investigations on alliin, the specific principle of garlicAdv Enzymol Relat Subj Biochem1137740019512454059610.1002/9780470122563.ch8 SlusarenkoAJPatelAPortzDControl of plant diseases by natural products: Allicin from garlic as a case studyEur J Plant Pathol1213133222008 BorlinghausJAlbrechtFGruhlkeMCNwachukwuIDSlusarenkoAJAllicin: Chemistry and biological propertiesMolecules19125911261820142515387310.3390/molecules190812591 UpadhyayRKGarlic: A potential source of pharmaceuticals and pesticides: A reviewInt J Green Phar101282016 Quintero-FabiánSOrtuño-SahagúnDVázquez-CarreraMLópez-RoaRIAlliin, a Garlic (Allium sativum) compound, prevents LPS-induced inflammation in 3T3-L1 adipocytesMediators Inflamm201338181520132445341610.1155/2013/381815 ZhangMShengSZhangWZhangJZhangZZhangMHatchGMChenLMiR27a promotes the development of macrophage-like characteristics in 3T3-L1 preadipocytesInt J Biol Sci141599160920183026301110.7150/ijbs.26274 LivakKJSchmittgenTDAnalysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) methodMethods2540240820011184660910.1006/meth.2001.1262 EkorMThe growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safetyFront Pharmacol417720142445428910.3389/fphar.2013.00177 AoyagiRFunakoshi-TagoMFujiwaraYTamuraHCoffee inhibits adipocyte differentiation via inactivation of PPARγBiol Pharm Bull371820182520142521274710.1248/bpb.b14-00378 LiaoCCOuTTHuangHPWangCJThe inhibition of oleic acid induced hepatic lipogenesis and the promotion of lipolysis by caffeic acid via up-regulation of AMP-activated kinaseJ Sci Food Agric941154116220142402711710.1002/jsfa.6386 WuTJiangZYinJLongHZhengXAnti-obesity effects of artificial planting blueberry (Vaccinium ashei) anthocyanin in high-fat diet-treated miceInt J Food Sci Nutr6725726420162689987210.3109/09637486.2016.1146235 PrinsJBO'RahillySRegulation of adipose cell number in manClin Sci (Lond)923111997903858610.1042/cs0920003 GuoLLiXTangQQTranscriptional regulation of adipocyte differentiation: A central role for CCAAT/enhancer-binding protein (C/EBP) βJ Biol Chem29075576120152545194310.1074/jbc.R114.619957 SalmaNXiaoHImbalzanoANTemporal recruitment of CCAAT/enhancer-binding proteins to early and late adipogenic promoters in vivoJ Mol Endocrinol3613915120061646193410.1677/jme.1.01918 TontonozPHuESpiegelmanBMStimulation of adipogenesis in fibroblasts by PPARgamma2, a lipid-activated transcription factorCell79114711561994800115110.1016/0092-8674(94)90006-x WangFMullicanSEDiSpiritoJRPeedLCLazarMALipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARγProc Natl Acad Sci USA110186561866120132416725610.1073/pnas.1314863110 IllescaPValenzuelaREspinosaAEcheverríaFSoto-AlarconSOrtizMVidelaLAHydroxytyrosol supplementation ameliorates the metabolic disturbances in white adipose tissue from mice fed a high-fat diet through recovery of transcription factors Nrf2, SREBP-1c, PPAR-γ and NF-κBBiomed Pharmacother1092472248120193055150810.1016/j.biopha.2018.11.120 EcheverríaFOrtizMValenzuelaRVidelaLALong-chain polyunsaturated fatty acids regulation of PPARs, signaling: Relationship to tissue development and agingProstaglandins Leukot Essent Fatty Acids114283420162792646110.1016/j.plefa.2016.10.001 WuZRosenEDBrunRHauserSAdelmantGTroyAEMcKeonCDarlingtonGJSpiegelmanBMCross-regulation of C/EBPα and PPARγ controls the transcriptional pathway of adipogenesis and insulin sensitivityMol Cell315115819991007819810.1016/s1097-2765(00)80306-8 TangQQOttoTCLaneMDCCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesisProc Natl Acad Sci USA10085085520031252569110.1073/pnas.0337434100 GhabenALSchererPEAdipogenesis and metabolic healthNat Rev Mol Cell Biol2024225820193061020710.1038/s41580-018-0093-z GerholdDLLiuFJiangGLiZXuJLuMSachsJRBagchiAFridmanAHolderDJGene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonistsEndocrinology1432106211820021202117510.1210/endo.143.6.8842 LukaszewskiMAEberléDVieauDBretonCNutritional manipulations in the perinatal period program adipose tissue in offspringAm J Physiol Endocrinol Metab305E1195E120720132404586910.1152/ajpendo.00231.2013 SonYHKaSKimAYKimJBRegulation of adipocyte differentiation via microRNAsEndocrinol Metab (Seoul)2912213520142503188410.3803/EnM.2014.29.2.122 SaltielARKahnCRInsulin signalling and the regulation of glucose and lipid metabolismNature41479980620011174241210.1038/414799a PengXDXuPZChenMLHahn-WindgassenASkeenJJacobsJSundararajanDChenWSCrawfordSEColemanKGHayNDwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2Genes Dev171352136520031278265410.1101/gad.1089403 TangQQGronborgMHuangHKimJWOttoTCPandeyALaneMDSequential phosphorylation of CCAAT enhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesisProc Natl Acad Sci USA1029766977120051598555110.1073/pnas.0503891102 TanabeYKogaMSaitoMMatsunagaYNakayamaKInhibition of adipocyte differentiation by mechanical stretching through ERK-mediated downregulation of PPARgamma2J Cell Sci1173605361420041525212810.1242/jcs.01207

Effect of alliin on lipid droplet accumulation in 3T3-L1 cells. (A) Phase-contrast images of 3T3-L1 cells. (A-a and -b) 3T3-L1 cells exhibited fibroblastic morphology before adipogenic induction, (c-f) and then the cells changed to a round-shape after 7 days of induction. (A-g-j) Oil-red O staining revealed that the intracellular lipids were decreased in alliin-treated groups compared with the control. (B) Quantitative analysis demonstrated that the positively stained areas were decreased in the alliin treatment group. (C) Cell viability was tested on day 7. Alliin (10-40 µg/ml) exhibited no effect on cell viability. Scale bar, 100 µm. Data are presented as the mean ± SEM. *P<0.05, **P<0.01, ***P<0.001.

Effect of alliin on adipogenic transcriptional markers during induction. The 3T3-L1 cells were treated with or without alliin during adipogenic induction. Reverse transcription-quantitative PCR revealed the expression levels of (A) C/EBP β, (B) C/EBP α and (C) PPAR γ in 3T3-L1 cells during induction. Data are presented as the mean ± SEM. *P<0.05, **P<0.01. C/EBP, CCAAT/enhancer-binding protein; PPAR γ, peroxisome proliferation-activity receptor γ.

Effect of alliin on adipocyte-related genes during induction. Alliin was administered at various concentrations during adipogenic differentiation. Reverse transcription-quantitative PCR analysis was used to evaluate the gene expression levels of (A) adiponectin, (B) Fabp4 and (C) leptin. Data are presented as the mean ± SEM. *P<0.05, **P<0.01. Fabp4, fatty acid binding protein 4.

Effect of alliin on the Akt and ERK 1/2 pathway-related genes during induction. The 3T3-L1 cells were treated with different concentration of alliin during adipogenesis. The expression levels of (A) PI3K, (B) Akt, (C) MAPK and (D) ERK were analyzed by reverse transcription-quantitative PCR. Data are presented as the mean ± SEM. *P<0.05, **P<0.01.

Schematic representation of the possible mechanism of the anti-adipogenic effect of alliin. Alliin (C6H11NO3S) inhibits adipogenesis by downregulating PI3K and Akt activity, thereby attenuating the expression levels of C/EBP β, C/EBP α, PPAR γ and lipid metabolizing enzymes. C/EBP, CCAAT/enhancer-binding protein; PPAR γ, peroxisome proliferation-activity receptor γ.

Primer sequences for reverse transcription-quantitative PCR.

Name of gene Primers (5'-3') Melting temperature (˚C) Product length (bp) Genbank code
β-actin F: CATCCGTAAAGACCTCTATGCCAAC ATGGAGCCACCGATCCACA 64.1 193 NM_007393.5
  R: ATGGAGCCACCGATCCACA 64.9    
PPAR γ F: GTGCCAGTTTCGATCCGTAGA 66.2 167 NM_001113418.1
  R: GGCCAGCATCGTGTAGATGA 66.2    
C/EBP α F: GGACAAGAACAGCAACGAGTA 61.8 237 NM_001287514.1
  R: GCAGTTGCCATGGCCTTGA 69.7    
C/EBP β F: TGGACAAGCTGAGCGACGAG 69.1 192 NM_001287738.1
  R: TGTGCTGCGTCTCCAGGTTG 70.0    
Adiponectin F: GCACTGGCAAGTTCTACTGCAA 66.4 156 NM_009605.5
  R: GTAGGTGAAGAGAACGGCCTTGT 66.4    
Leptin F: CCACACACAGCTGGAAACTC 63.4 216 NM_008493.3
  R: GCCTTGCTTCAGATCCATCC 65.9    
Fabp4 F: CCAATGAGCAAGTGGCAAGA 66.2 179 NM_024406.3
  R: GATGCCAGGCTCCAGGATAG 65.9    
PI3K F: TCCTGCTTCATACCGAGCTT 63.8 212 NM_001024955.2
  R: CATGACATCCTCCCTCTCGT 64.2    
AKT F: CCCTTCTACAACCAGGACCA 63.9 210 NM_009652.3
  R: ATACACATCCTGCCACACGA 64.1    
MAPK F: TGCCAGGCTGAACTACAGTG 64.1 169 NM_008927.4
  R: CACAAGGCTCCCTCTCAGAC 64.1    
ERK F: TCAGAGGCAGGTGGATCTCT 64.0 188 NM_011949.3
  R: GGTGCCATCATCAACATCTG 64.1    

F, forward; R, reverse.